The Celiac Disease market size is USD 1.3 Bn in 2026.
The Celiac Disease market is projected to grow at a CAGR of 10% by 2033, reaching USD 2.6 Bn.
The Celiac Disease market growth drivers include rising disease awareness, expanding gluten-free product adoption, and increasing research in diagnostics and treatment options.
North America is a dominating region for the Celiac Disease market.
Takeda Pharmaceutical Company Limited, AbbVie Inc., Merck & Co., Inc., Sanofi, and Novartis AG are some leading industry players in the Celiac Disease market.
Quality assured
Buy now
Report Description
Research Methodology
